UBS AM Portfolio holdings
UBS Asset Management (UBS AM), a division of UBS Group AG with origins tied to the bank’s founding in 1862, is headquartered in Zurich, Switzerland, and manages hundreds of billions in assets for institutional, intermediary, and wealth management clients globally. Specializing in a broad range of investment strategies—including equities, fixed income, multi-asset, alternatives, and sustainable investing—UBS AM leverages the firm’s extensive research capabilities and global network to deliver tailored solutions. Known for its focus on risk management and innovation, it offers products like ETFs, index funds, and private market investments, catering to diverse needs from pension funds to high-net-worth individuals. As part of UBS’s broader ecosystem, UBS AM combines Swiss precision with a commitment to ESG principles, solidifying its position as a leader in the asset management industry.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
AGN
Allergan plc
AGN
|
+$155M |
| 2 |
Wells Fargo
WFC
|
+$134M |
| 3 |
Biogen
BIIB
|
+$121M |
| 4 |
Alibaba
BABA
|
+$108M |
| 5 |
Delta Air Lines
DAL
|
+$107M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Scotiabank
BNS
|
+$255M |
| 2 |
Chevron
CVX
|
+$220M |
| 3 |
Bank of Montreal
BMO
|
+$192M |
| 4 |
Canadian Imperial Bank of Commerce
CM
|
+$191M |
| 5 |
Enbridge
ENB
|
+$174M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 18.93% |
| 2 | Financials | 14.16% |
| 3 | Healthcare | 13.87% |
| 4 | Consumer Discretionary | 11.78% |
| 5 | Industrials | 8.62% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
1101
Thor Industries
THO
$4.14B
| $5.06M | ﹤0.01% |
60,457
-19,829
| -25% | -$1.9M |
|
|
SNV
1102
DELISTED
Synovus
SNV
| $5.04M | ﹤0.01% |
110,120
-4,345
| -4% | -$219K |
|
|
UFS
1103
DELISTED
DOMTAR CORPORATION (New)
UFS
| $5M | ﹤0.01% |
95,812
-163
| -0.2% | -$8.21K |
|
|
NCNA
1104
NuCana
NCNA
$6.12M
| $5M | ﹤0.01% |
40
-9
| -18% | -$1.06M |
|
1105
Graphic Packaging
GPK
$3.58B
| $4.97M | ﹤0.01% |
354,617
-4,363
| -1% | -$62.9K |
|
|
AL
1106
DELISTED
Air Lease Corp
AL
| $4.95M | ﹤0.01% |
107,856
+1,310
| +1% | +$58.4K |
|
1107
Euronet Worldwide
EEFT
$2.7B
| $4.92M | ﹤0.01% |
49,059
+934
| +2% | +$88K |
|
1108
Crane NXT
CXT
$3.07B
| $4.91M | ﹤0.01% |
143,823
| – | – |
|
1109
First Horizon
FHN
$12.1B
| $4.88M | ﹤0.01% |
283,014
+27,397
| +11% | +$494K |
|
1110
GDS Holdings
GDS
$6.41B
| $4.88M | ﹤0.01% |
138,891
+28,917
| +26% | +$1.04M |
|
1111
Nu Skin
NUS
$267M
| $4.85M | ﹤0.01% |
58,874
-2,067
| -3% | -$164K |
|
1112
Four Corners Property Trust
FCPT
$2.75B
| $4.85M | ﹤0.01% |
188,825
+9,560
| +5% | +$247K |
|
|
JHG
1113
DELISTED
Janus Henderson
JHG
| $4.81M | ﹤0.01% |
178,297
+2,503
| +1% | +$73K |
|
1114
Five Below
FIVE
$13.5B
| $4.79M | ﹤0.01% |
36,820
+119
| +0.3% | +$13.2K |
|
|
DNR
1115
DELISTED
Denbury Resources, Inc.
DNR
| $4.79M | ﹤0.01% |
772,108
-18,197
| -2% | -$90.8K |
|
1116
Cabot Corp
CBT
$4.52B
| $4.78M | ﹤0.01% |
76,234
+694
| +0.9% | +$44.6K |
|
|
UMPQ
1117
DELISTED
Umpqua Holdings Corp
UMPQ
| $4.75M | ﹤0.01% |
228,535
+9,275
| +4% | +$203K |
|
|
MDR
1118
DELISTED
McDermott International
MDR
| $4.74M | ﹤0.01% |
257,166
-21
| -0% | -$393 |
|
1119
Dolby
DLB
$5.79B
| $4.73M | ﹤0.01% |
67,643
+2,015
| +3% | +$135K |
|
1120
New Jersey Resources
NJR
$5.58B
| $4.72M | ﹤0.01% |
102,394
+1,301
| +1% | +$60K |
|
1121
White Mountains Insurance
WTM
$5.13B
| $4.71M | ﹤0.01% |
5,028
+65
| +1% | +$60.2K |
|
|
TIER
1122
DELISTED
TIER REIT, Inc.
TIER
| $4.68M | ﹤0.01% |
194,259
+18,582
| +11% | +$440K |
|
1123
Vanguard FTSE Emerging Markets ETF
VWO
$124B
| $4.68M | ﹤0.01% |
114,159
-105,188
| -48% | -$4.43M |
|
|
PRAH
1124
DELISTED
PRA Health Sciences, Inc.
PRAH
| $4.68M | ﹤0.01% |
42,461
+4,112
| +11% | +$428K |
|
1125
iShares Core MSCI Europe ETF
IEUR
$9.16B
| $4.68M | ﹤0.01% |
97,508
+13,792
| +16% | +$664K |
|
Similar funds
UBS AM's Q3 2018 Portfolio in Review
As of Q3 2018, UBS AM held 2,869 positions worth $135B, up 3.1% from $130B the previous quarter. Its ten largest holdings account for 18% of the portfolio.
UBS AM's Q3 2018 filing shows 86 new, 1,174 increased, 804 reduced and 106 closed positions. Its largest new stake was Athene Holding Ltd. Class A Common Shares: 1,079,023 shares worth $55.7M. The largest sale was Scotiabank, an estimated $255M.
By sector, the portfolio is most concentrated in Technology at 19% of assets, up from 18% a quarter earlier, followed by Financials and Healthcare.
- UBS AM's largest Q3 2018 buy was Athene Holding Ltd. Class A Common Shares: 1,079,023 shares worth $55.7M.
- UBS AM added most to Allergan plc in Q3 2018, an estimated $155M increase.
- UBS AM's biggest Q3 2018 reduction was Scotiabank, cutting an estimated $255M.
- UBS AM fully exited BCE in Q3 2018, selling an estimated $35M.
- UBS AM's ten largest holdings make up 18% of its $135B portfolio in Q3 2018.
- UBS AM opened 86 new positions and closed 106 in Q3 2018.
- UBS AM's portfolio value rose 3.1% quarter-over-quarter to $135B.
Based on UBS AM's 13F filing for Q3 2018, filed 14 Nov 2018.